Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
Amyotrophic lateral sclerosis (ALS) is an incurable adult-onset motor neuron degenerative disease, characterized by loss of both upper and lower motor neurons. In this study, we focused on RNA-biniding proteins (RBPs) including TDP-43, FUS, and hnRNPA1 that are thought to be closely linked to the pathogenesis of ALS. We elucidated the molecular pathomechanisms underlying RBPs-induced neuronal cell death. We have plans to develop therapeutic drugs for ALS that target RBPs-related neuronal cell death.
|